Chargement en cours...
Comparative analysis of antiviral efficacy of FDA‐approved drugs against SARS‐CoV‐2 in human lung cells
Drug repositioning represents an effective way to control the current COVID‐19 pandemic. Previously, we identified 24 FDA‐approved drugs which exhibited substantial antiviral effect against severe acute respiratory syndrome coronavirus 2 in Vero cells. Since antiviral efficacy could be altered in di...
Enregistré dans:
| Publié dans: | J Med Virol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7436731/ https://ncbi.nlm.nih.gov/pubmed/32767684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26397 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|